Rapamycin sensitizes cancer cells to growth inhibition by the PARP inhibitor olaparib

por Osoegawa, Atsushi, Gills, Joell J., Kawabata, Shigeru, Dennis, Phillip A.
Publicado 2017

Relationship Between Progression‐Free Survival, Objective Response Rate, and Overall Survival in Clinical Trials of PD‐1/PD‐L1 Immune Checkpoint Blockade: A Meta‐Analysis

por Ye, Jiabu, Ji, Xiang, Dennis, Phillip A., Abdullah, Hesham, Mukhopadhyay, Pralay
Publicado 2020

Assessing the Influence of Subsequent Immunotherapy on Overall Survival in Patients with Unresectable Stage III Non–Small Cell Lung Cancer from the PACIFIC Study

por Ouwens, Mario, Darilay, Annie, Zhang, Yiduo, Mukhopadhyay, Pralay, Mann, Helen, Ryan, James, Dennis, Phillip A.
Publicado 2021

Molecular pathways and therapeutic targets in lung cancer

por Shtivelman, Emma, Hensing, Thomas, Simon, George R., Dennis, Phillip A., Otterson, Gregory A., Bueno, Raphael, Salgia, Ravi
Publicado 2014

Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia

por Chang, Yoon Soo, Gills, Joell J., Kawabata, Shigeru, Onozawa, Masahiro, Della Gatta, Giusy, Ferrando, Adolfo A., Aplan, Peter D., Dennis, Phillip A.
Publicado 2023

A Novel Classification of Lung Cancer into Molecular Subtypes

por West, Lisandra, Vidwans, Smruti J., Campbell, Nicholas P., Shrager, Jeff, Simon, George R., Bueno, Raphael, Dennis, Phillip A., Otterson, Gregory A., Salgia, Ravi
Publicado 2012

Rapamycin downregulates thymidylate synthase and potentiates the activity of pemetrexed in non-small cell lung cancer

por Kawabata, Shigeru, Chiang, Chun-Te, Tsurutani, Junji, Shiga, Hideaki, Arwood, Matthew L., Komiya, Takefumi, Gills, Joell J., Memmott, Regan M., Dennis, Phillip A.
Publicado 2014

Immune Evasion by Murine Melanoma Mediated through CC Chemokine Receptor-10

por Murakami, Takashi, Cardones, Adela R., Finkelstein, Steven E., Restifo, Nicholas P., Klaunberg, Brenda A., Nestle, Frank O., Castillo, S. Sianna, Dennis, Phillip A., Hwang, Sam T.
Publicado 2003

Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status

por Baverel, Paul G., Dubois, Vincent F.S., Jin, Chao Yu, Zheng, Yanan, Song, Xuyang, Jin, Xiaoping, Mukhopadhyay, Pralay, Gupta, Ashok, Dennis, Phillip A., Ben, Yong, Vicini, Paolo, Roskos, Lorin, Narwal, Rajesh
Publicado 2018

Loss of Cytoplasmic CDK1 Predicts Poor Survival in Human Lung Cancer and Confers Chemotherapeutic Resistance

por Zhang, Chunyu, Elkahloun, Abdel G., Robertson, Matthew, Gills, Joell J., Tsurutani, Junji, Shih, Joanna H., Fukuoka, Junya, Hollander, M. Christine, Harris, Curtis C., Travis, William D., Jen, Jin, Dennis, Phillip A.
Publicado 2011

A Pilot Study of Sirolimus in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in PTEN

por Komiya, Takefumi, Blumenthal, Gideon M., DeChowdhury, Roopa, Fioravanti, Susan, Ballas, Marc S., Morris, John, Hornyak, Thomas J., Wank, Stephen, Hewitt, Stephen M., Morrow, Betsy, Memmott, Regan M., Rajan, Arun, Dennis, Phillip A.
Publicado 2019

A Central Role for Foxp3+ Regulatory T Cells in K-Ras-Driven Lung Tumorigenesis

por Granville, Courtney A., Memmott, Regan M., Balogh, Andria, Mariotti, Jacopo, Kawabata, Shigeru, Han, Wei, LoPiccolo, Jaclyn, Foley, Jason, Liewehr, David J., Steinberg, Seth M., Fowler, Daniel H., Hollander, M. Christine, Dennis, Phillip A.
Publicado 2009

Regulation of RhoB Gene Expression during Tumorigenesis and Aging Process and Its Potential Applications in These Processes

por Gutierrez, Eutiquio, Cahatol, Ian, Bailey, Cedric A.R., Lafargue, Audrey, Zhang, Naming, Song, Ying, Tian, Hongwei, Zhang, Yizhi, Chan, Ryan, Gu, Kevin, Zhang, Angel C.C., Tang, James, Liu, Chunshui, Connis, Nick, Dennis, Phillip, Zhang, Chunyu
Publicado 2019

A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors

por Blumenthal, Gideon M., Gills, Joell J., Ballas, Marc S., Bernstein, Wendy B., Komiya, Takefumi, Dechowdhury, Roopa, Morrow, Betsy, Root, Hyejeong, Chun, Guinevere, Helsabeck, Cynthia, Steinberg, Seth M., LoPiccolo, Jaclyn, Kawabata, Shigeru, Gardner, Erin R., Figg, William D., Dennis, Phillip A.
Publicado 2014

Epidermal growth factor receptor as a novel molecular target for aggressive papillary tumors in the middle ear and temporal bone

por Kawabata, Shigeru, Christine Hollander, M, Munasinghe, Jeeva P., Brinster, Lauren R., Mercado-Matos, José R., Li, Jie, Regales, Lucia, Pao, William, Jänne, Pasi A., Wong, Kwok-Kin, Butman, John A., Lonser, Russell R., Hansen, Marlan R., Gurgel, Richard K., Vortmeyer, Alexander O., Dennis, Phillip A.
Publicado 2015

Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC

por Gray, Jhanelle E., Villegas, Augusto, Daniel, Davey, Vicente, David, Murakami, Shuji, Hui, Rina, Kurata, Takayasu, Chiappori, Alberto, Lee, Ki Hyeong, Cho, Byoung Chul, Planchard, David, Paz-Ares, Luis, Faivre-Finn, Corinne, Vansteenkiste, Johan F., Spigel, David R., Wadsworth, Catherine, Taboada, Maria, Dennis, Phillip A., Özgüroğlu, Mustafa, Antonia, Scott J.
Publicado 2019